Evidence map›Paper›PMID 34789332›Full record

ReviewTranslational neurodegeneration2021

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.

Frances Theunissen, Phillip K West, Samuel Brennan, Bojan Petrović, Kosar Hooshmand, P Anthony Akkari, Matt Keon, Boris Guennewig

Open access · goldAbstract readReview
In one paragraph

Review in Translational neurodegeneration, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Cerebral metabolic patterns onEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. PathogenicHuman mutation · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Frances TheunissenPerron Institute for Neurological and Translational Science, Nedlands, WA, Australia. frances.theunissen@perron.uwa.edu.au.ORCID 0000-0002-7092-8344
Phillip K WestGenieUs Genomics Pty Ltd, Sydney, NSW, Australia.
Samuel BrennanGenieUs Genomics Pty Ltd, Sydney, NSW, Australia.
Bojan PetrovićGenieUs Genomics Pty Ltd, Sydney, NSW, Australia.
Kosar HooshmandGenieUs Genomics Pty Ltd, Sydney, NSW, Australia.
P Anthony AkkariPerron Institute for Neurological and Translational Science, Nedlands, WA, Australia.
Matt KeonGenieUs Genomics Pty Ltd, Sydney, NSW, Australia. mattk@genieus.co.
Boris GuennewigGenieUs Genomics Pty Ltd, Sydney, NSW, Australia.
The University of Sydney · AUDuke University · USGendarmerie Nationale · FRMurdoch University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by selective, early degeneration of motor neurons in the brain and spinal cord. Motor neurons have long axonal projections, which rely on the integrity of neuronal cytoskeleton and mitochondria to regulate energy requirements for maintaining axonal stability, anterograde and retrograde transport, and signaling between neurons. The formation of protein aggregates which contain cytoskeletal proteins, and mitochondrial dysfunction both have devastating effects on the function of neurons and are shared pathological features across several neurodegenerative conditions, including ALS, Alzheimer's disease, Parkinson's disease, Huntington's disease and Charcot-Marie-Tooth disease. Furthermore, it is becoming increasingly clear that cytoskeletal integrity and mitochondrial function are intricately linked. Therefore, dysregulations of the cytoskeletal network and mitochondrial homeostasis and localization, may be common pathways in the initial steps of neurodegeneration. Here we review and discuss known contributors, including variants in genetic loci and aberrant protein activities, which modify cytoskeletal integrity, axonal transport and mitochondrial localization in ALS and have overlapping features with other neurodegenerative diseases. Additionally, we explore some emerging pathways that may contribute to this disruption in ALS.

Indexed as

Amyotrophic Lateral SclerosisNeurodegenerative DiseasesCytoskeletonHumansMitochondriaMotor NeuronsAmyotrophic lateral sclerosisAxonal transportCytoskeletonGut microbiomeMitochondriaNeurodegenerationNeurofilament

Identifiers

PMID34789332
PMCPMC8597313
OpenAlexW3214243101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.